For companies in the advanced therapeutics space, collaboration with major pharmaceutical companies and licensing agreements with universities can accelerate innovation and market entry. However, these partnerships come with their own set of challenges, from IP ownership and data rights to regulatory hurdles and commercialization terms. This panel will offer guidance on navigating these complex relationships to maximize benefits and mitigate risks.

Key discussion points will include:

• Negotiating IP rights and ownership to align with both short-term R&D goals and long-term commercialization strategies
• Protecting proprietary data, managing shared research results, and establishing clear boundaries around data use and access
• Understanding regulatory obligations, compliance requirements, and risk-sharing strategies in partnerships that span global markets
• Designing financial arrangements, including royalties, milestone payments, and profit-sharing, to ensure alignment and value creation for both parties